Abbott
Also known as: Abbott | ABBOTT | Abbott Biologicals | Abbott Biotherapeutics Corp. | Abbott (China) | Abbott Diabetes Care | Abbott Diabetes Care Inc | Abbott Diagnostics Division | Abbott Germany, Medical Department | Abbott Healthcare Products BV | Abbott Healthcare Products B.V | Abbott Healthcare Products B.V. | Abbott India Ltd. | Abbott Japan | Abbott Japan Co.,Ltd | Abbott Laboratories, Poland | Abbott Laboratories - Saudi Arabia | Abbott Laboratories S.A., Ukraine | ABBOTT LABS | Abbott Labs PPD R&D | Abbott Medical Devices | Abbott Medical Devices Neuromodulation | Abbott Medical Optics | Abbott Northwestern Hospital | Abbott Nutrition | Abbott Nutrition Research & Development | Abbott Products | Abbott Rapid Dx | Abbott Structural Heart | Abbott Transfusion Medicine | Abbott Vascular | Clinical Program Director | GynoPharm | Minneapolis Heart / Abbott Northwestern | Recalcine (GynoPharm) | Renal Global Project Team, Abbott Laboratories | ROSS LABS | Ross Products | Ross Products Division of Abbott Laboratories
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1991First marketed drug
Jan 25, 1946First NDA
Jan 25, 1946Last known activity
Jul 1, 2026
Timeline
1880s
- Jan 1, 1888
Abbott— Founded
1980s
- Aug 7, 1987
terazosin— NDA Organization
- Feb 3, 1989
nalbuphine— Marketing Organization
2000s
- Dec 15, 2000
Knoll— Acquired
- Nov 6, 2006
Kos Pharmaceuticals— Acquired
- Jan 1, 2009
Solvay— Acquired
2010s
- Jan 1, 2010
Facet Biotech— Acquired
- Jan 1, 2012
Action Pharma A/S— Acquired
- Aug 19, 2013
OptiMedica Corporation— Acquired - Aug 21, 2013
IDev Technologies— Acquired
- Oct 29, 2014
Topera Medical— Acquired
- Dec 12, 2014
Veropharm— Acquired
- Jul 30, 2015
Tendyne Holdings— Acquired - Feb 2, 2016
Kalila Medical— Acquired
- Apr 28, 2016
St. Jude Medical— Acquired
Drugs by trial phase (324 distinct, 799 trials)
Phase 4 (59 own, 44 via acquisition)
Phase 3 (41 own, 32 via acquisition)
Phase 2 (37 own, 28 via acquisition)
Phase 1 (25 own, 13 via acquisition)
Other trials (27 own, 18 via acquisition)
Indications
Approved for
- Anemia, Megaloblastic
- Anxiety
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Attention Deficit Disorder with Hyperactivity
- Autistic Disorder
- Colitis, Ulcerative
- Colorectal Neoplasms
- Common Cold
- Dermatitis Herpetiformis
- Dyslipidemias
- Epilepsy
- Epilepsy, Absence
- Epilepsy, Generalized
- Glaucoma, Open-Angle
- Gout
- Hepatitis C
- Hepatitis C, Chronic
- HIV Infections
- Hypercholesterolemia
- Hypersensitivity
- Hypertension
- Hypertriglyceridemia
- Infections
- Inflammation
- Leprosy
- Leukemia, Myeloid, Chronic-Phase
- Narcolepsy
- Obesity
- Ocular Hypertension
- Osteosarcoma
- Pain
- Parenteral Nutrition
- Polycythemia Vera
- Prostatic Hyperplasia
- Psoriasis
- Rhinitis, Allergic, Seasonal
- Seizures
- Shock
- Skin Diseases
- Sleep Initiation and Maintenance Disorders
- Spondylitis, Ankylosing
- Thyroid Diseases
- Tuberculosis, Pulmonary
Studied for
- Abortion, Habitual
- Abortion, Spontaneous
- Acquired Immunodeficiency Syndrome
- Acute Disease
- Acute Kidney Injury
- Acute Pain
- Adenocarcinoma
- Albuminuria
- Alcoholism
- Alcohol-Related Disorders
- Alzheimer Disease
- Amenorrhea
- Apnea
- Arteritis
- Arthritis
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Asthma
- Atherosclerosis
- Atrophy
- Attention Deficit Disorder with Hyperactivity
- Avitaminosis
- Back Pain
- Behavioral Symptoms
- Behcet Syndrome
- Binge-Eating Disorder
- Bipolar Disorder
- Body-Weight Trajectory
- Brain Injuries
- Brain Injuries, Traumatic
- Breast Neoplasms
- Bronchitis
- Bronchitis, Chronic
- Bronchopulmonary Dysplasia
- Bulimia
- Calcinosis
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Cardiovascular Diseases
- Carotid Artery Diseases
- Celiac Disease
- Cholangiocarcinoma
- Cholestasis
- Cholestasis, Intrahepatic
- Cognition Disorders
- Coinfection
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Communicable Diseases
- Constipation
- Coronary Artery Disease
- Coronary Disease
- Coronary Restenosis
- Coronary Stenosis
- Crohn Disease
- Cystic Fibrosis
- Cystitis
- Cystitis, Interstitial
- Delirium
- Dementia
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diabetic Retinopathy
- Diarrhea
- Diarrhea, Infantile
- Digestive System Diseases
- Digestive System Neoplasms
- Disease
- Dry Eye Syndromes
- Dyskinesias
- Dyslipidemias
- Edema
- Endometrial Neoplasms
- Endometriosis
- Enterocolitis
- Epilepsies, Partial
- Epilepsy
- Epilepsy, Reflex
- Esophageal Neoplasms
- Essential Hypertension
- Exocrine Pancreatic Insufficiency
- Fallopian Tube Neoplasms
- Fatty Liver
- Feeding and Eating Disorders
- Fibrosis
- Flushing
- Fractures, Bone
- Gastrointestinal Diseases
- Gastrointestinal Neoplasms
- Genital Diseases, Female
- Genital Diseases, Male
Marketed drugs (83)
Subsidiaries (14 direct, 29 total across the full acquisition tree)
- Action Pharma A/S
- Cardiovascular Systems
- Facet Biotech
- Helopharm
- IDev Technologies
- Kalila Medical
- Knoll
- Kos Pharmaceuticals
- OptiMedica Corporation
- Solvay
- St. Jude Medical
- Tendyne Holdings
- Topera Medical
- Veropharm
- Chemlogics L2
- Fournier Labs L2
- PDL BioPharma L2
- Philips L2
- Plextronics L2
- Reid-Rowell, Inc L2
- Replidyne L2
- Unimed Pharmaceuticals L2
- Avent L3
- Discus Dental L3
- ESP Pharma L3
- Reid Provident Labs L3
- Rowell Laboratories L3
- Xhale Assurance L3
- Xhale Smart, Inc. L3
Recent trials (50)
- NCT06321705CollaboratorN/A—
- NCT07211802CollaboratorPhase 3Jul 1, 2026
- NCT07198529CollaboratorN/ASep 30, 2025
- NCT06883864CollaboratorN/AApr 1, 2025
- NCT06217393Lead sponsorPhase 3Feb 28, 2024
- NCT05705427CollaboratorPhase 4Aug 17, 2023
- NCT05525039CollaboratorN/AOct 31, 2022
- NCT05491200CollaboratorPhase 4Jul 22, 2022
- NCT05387954CollaboratorPhase 3Jun 1, 2022
- NCT05198791CollaboratorPhase 2Feb 4, 2022
- NCT04865978CollaboratorPhase 2Dec 1, 2021
- NCT04957992Study chairN/AJul 21, 2021
- NCT04957992Lead sponsorN/AJul 21, 2021
- NCT05519514Lead sponsorPhase 1Jul 12, 2021
- NCT05519514Study directorPhase 1Jul 12, 2021
Details
- Founded
- Lake Bluff, IL, US Jan 1, 1888
- First NDA
- Jan 25, 1946
- Last known activity
- Jul 1, 2026
Designations held
- Fast track
- Priority review
- Accelerated approval